Internal Medicine

A new oral delivery system may replace injections for people with diabetes.

Researchers simultaneously increased the potency of a cancer drug while reducing both the required dose and the side effects, all by using a surprising new drug delivery vehicle: bacteria.

Gut bacteria tailored to a child’s diet may help treat malnutrition.

Scientists found that the Kisspeptin hormone activates enzymes that stop lipid formation in the mouse liver, suggesting that it has potential as a drug target for treating non-alcoholic fatty liver disease.

Advances in data integration enable scientists to combine multiomics data and a patient’s clinical record to develop precision medicine approaches for treating disease.

Chemical biologist Stefano Tiziani uses metabolomics to identify new combination cancer treatments and to predict which patients will respond best to chemotherapy.

A new heart-on-a-chip gives scientists an up-close look at the beating human heart from the comfort of their lab benches.

An obesity medicine clinician researcher propels a growing movement to normalize obesity as a disease that requires long-term treatment.

Phenotypic screening may offer an alternative to traditional drug discovery.

Usually thrown away as waste, menstrual blood may help clinicians non-invasively monitor and diagnose a multitude of health conditions from diabetes and endometriosis to cancer.